Roche
ROG.SW
#31
Rank
NZ$615.33 B
Marketcap
NZ$773.41
Share price
2.30%
Change (1 day)
43.85%
Change (1 year)

EPS for Roche (ROG.SW)

EPS in 2024: NZ$19.17

According to Roche's latest financial reports the company's current EPS (TTM) is NZ$19.17. In 2024 the company made an earnings per share (EPS) of NZ$19.17 a decrease over its 2023 EPS that were of NZ$28.54.

EPS history for Roche from 1998 to 2024

Annual EPS

Year EPS Change
2024NZ$19.17-32.84%
2023NZ$28.541.95%
2022NZ$27.99-6.29%
2021NZ$29.87-5.53%
2020NZ$31.6216.56%
2019NZ$27.1330.3%
2018NZ$20.8220.22%
2017NZ$17.32-5.81%
2016NZ$18.384.62%
2015NZ$17.57-5.13%
2014NZ$18.52-25.05%
2013NZ$24.7221.73%
2012NZ$20.303.82%
2011NZ$19.568.16%
2010NZ$18.0823.72%
2009NZ$14.61-12.31%
2008NZ$16.66-0.34%
2007NZ$16.7232.13%
2006NZ$12.6542.56%
2005NZ$8.88-22.7%
2004NZ$11.48132.85%
2003NZ$4.93-147.82%
2002NZ-$10.31-209.09%
2001NZ$9.45-57.03%
2000NZ$22.0053.29%
1999NZ$14.3531.24%
1998NZ$10.94

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$17.39-9.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.26-36.02%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.87-85.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.42-29.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$21.71 13.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$6.17-67.79%๐Ÿ‡ซ๐Ÿ‡ท France
Becton Dickinson
BDX
NZ$9.28-51.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.65-33.98%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.99-68.74%๐Ÿ‡ฌ๐Ÿ‡ง UK